Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2003298596 (hide)

Owner Merck & Co., Inc.

Inventors Liang, Gui-Bai; Feng, Danqing Dennis; Qian, Xiaoxia; Biftu, Tesfaye; Weber, Ann E.

Agent Spruson & Ferguson

Pub. Number AU-B-2003298596

PCT Number PCT/US2003/0322

PCT Pub. Number WO2004/037169

Priority 60/419,703 18.10.02 US

Filing date 14 October 2003

Wipo publication date 13 May 2004

Acceptance publication date 18 December 2008

International Classifications

C07D 243/08 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 307/94 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 491/107 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/419,703 18.10.02 US

17 June 2004 Application Open to Public Inspection

  Published as AU-B-2003298596

18 December 2008 Application Accepted

  Published as AU-B-2003298596

23 April 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003298597-NOx MONITOR USING DIFFERENTIAL MOBILITY SPECTROMETRY

2003298595-SEMICONDUCTOR STACKED MULTIPACKAGE MODULE HAVING INVERTED SECOND PACKAGE